Table 2.
Baseline characteristics of patients with central serous chorioretinopathy included in the current study
| Demographic and/or clinical feature | aCSC n = 60 | cCSC n = 100 | p value |
|---|---|---|---|
| Age, years, mean ± SD | 48.0 ± 11.2 | 55.7 ± 10.4 | < 0.001 |
| Sex, n (%) | |||
| Male | 46 (77.6) | 79 (79.0) | 0.705 |
| Female | 14 (22.4) | 21 (21.0) | |
| Laterality, n (%) | |||
| Right | 33 (55.0) | 49 (49.0) | 0.737 |
| Left | 27 (45.0) | 51 (51.0) | |
| Ethnicity, n (%) | |||
| Caucasian | 55 (91.7) | 85 (85.0) | |
| Asian | 0 (0) | 2 (2.0) | |
| Hispanic | 2 (3.3) | 1 (1.0) | 0.225 |
| Middle East-Arabic | 3 (5.0) | 12 (12.0) | |
| Baseline SE, D, mean ± SD | + 0.56 D ± 1.58 | + 0.74 D ± 3.1 | 0.144 |
| Steroid use n (%) | 16 (26.6) | 17 (17.0) | 0.163 |
aCSC = acute central serous chorioretinopathy; cCSC = chronic central serous chorioretinopathy, SD = standard deviation, SE = standard error